Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL28670203 | 0.98 | CPT2 (0.31) | CPT2ACLY | |
| SCHEMBL290603 | 0.98 | CPT2 (0.32) | CPT2ACLY | |
| SCHEMBL28954899 | 0.97 | CPT2 (0.32) | CPT2ACLY | |
| SCHEMBL3647978 | 0.97 | CPT2 (0.32) | CPT2ACLY | |
| SCHEMBL28778140 | 0.97 | CPT2 (0.32) | CPT2ACLY | |
| SCHEMBL28954895 | 0.97 | CPT2 (0.32) | CPT2ACLY | |
| SCHEMBL3955192 | 0.97 | CPT2 (0.32) | CPT2ACLY | |
| SCHEMBL28307091 | 0.97 | CPT2 (0.32) | CPT2ACLY | |
| SCHEMBL27553304 | 0.91 | — | — | |
| SCHEMBL290602 | 0.87 | SMN1; SMN2 (0.41) | CPT2ACLY |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2282 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122075553-A | Composition of metagen and calcium salt and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122030507-A | Soft chewing tablet for improving joint health of pets and preparation method thereof | 广州威诺动物药业有限公司 | 2026-05-15 | — | — | CN | claimed |
| US-12550914-B2 | Whey-based nutritional compositions fortified with calcium | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2026-02-17 | — | — | US | claimed |
| CN-119924527-A | Composition for promoting bone health and bone formation, application and product thereof | 合生元(长沙)营养食品有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-119745049-A | Nutritional composition for preventing and improving senile osteoporosis and preparation method thereof | 浙江省海洋开发研究院 | 2025-04-04 | — | — | CN | claimed |
| EP-4529458-A1 | NUTRACEUTICAL OR PHARMACEUTICAL COMPOSITION FOR MALE INFERTILITY | Neilos S.r.l. (IT) | 2025-04-02 | — | — | EP | claimed |
| CN-119699587-A | Health-care nutrient solution and preparation method thereof | 丘瑞坤 | 2025-03-28 | — | — | CN | claimed |
| EP-4223128-B1 | USE OF AN ACTIVATABLE, DEESTERIFIED, PECTIN-CONVERTED FRUIT FIBER FOR MAKING SAUSAGES WITHOUT ADDED PHOSPHATES OR MEAT SUBSTITUTES | HERBSTREITH & FOX GMBH & CO KG PEKTIN FABRIKEN (DE) | 2025-03-26 | — | — | EP | claimed |
| CN-119679165-A | Mineral composition, and product and application thereof | 内蒙古伊利实业集团股份有限公司 | 2025-03-25 | — | — | CN | claimed |
| EP-4521952-A1 | REACTIVE GRANULATION OF CALCIUM CITRATE MALATE, DICALCIUM MALATE, AND DIMAGNESIUM MALATE | Balchem Corporation (US) | 2025-03-19 | — | — | EP | claimed |
| US-5128374-A | Use of calcium citrate malate for the treatment of osteoporosis and related disorders | THE PROCTER & GAMBLE COMPANY (US) | 1992-07-07 | — | — | US | claimed |
| US-5118513-A | Method for enhancing bioavailability of iron-calcium mineral supplements | THE PROCTER & GAMBLE COMPANY (US) | 1992-06-02 | — | — | US | claimed |
| WO-1992007475-A1 | CALCIUM FORTIFIED SAUCES | THE PROCTER & GAMBLE COMPANY (US) | 1992-05-14 | — | — | WO | claimed |
| US-5108761-A | METHOD OF PREVENTING TOOTH ENAMEL EROSION UTILIZING AN ACIDIC BEVERAGE CONTAINING CALCIUM | THE PROCTER & GAMBLE COMPANY (US) | 1992-04-28 | — | — | US | claimed |
| WO-1992005711-A1 | TOOTH ENAMEL EROSION INHIBITOR | THE PROCTER & GAMBLE COMPANY (US) | 1992-04-16 | — | — | WO | claimed |
| WO-1992002235-A1 | CALCIUM AND TRACE MINERAL SUPPLEMENTS | THE PROCTER & GAMBLE COMPANY (US) | 1992-02-20 | — | — | WO | claimed |
| WO-1991019692-A2 | CALCIUM CITRATE MALATE COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 1991-12-26 | — | — | WO | claimed |
| EP-0304987-A2 | Novel calcium supplements | Norwich Eaton Pharmaceuticals, Inc. (US) | 1989-03-01 | — | — | EP | claimed |
| EP-0304986-A2 | The use of certain Calcium-Citrate-Malate for the manufacture of a medicament for the treatment of osteoporosis | Norwich Eaton Pharmaceuticals, Inc. (US) | 1989-03-01 | — | — | EP | claimed |
| EP-0297681-A2 | Iron-calcium mineral supplements with enhanced bioavailability | THE PROCTER & GAMBLE COMPANY (US) | 1989-01-04 | — | — | EP | claimed |